RalphS.FreedmanMD
Obstetrics & Gynecology • Houston, TXGeneral Gynecology, Gynecologic Oncology
Physician
Dr. Freedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
N/A
Houston, TX 77030- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1976 - 1976
University of the WitwatersrandClass of 1965
Certifications & Licensure
FL State Medical License 2018 - 2026
TX State Medical License 1977 - 2020- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer Start of enrollment: 1997 Oct 01
- Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- 10 citationsDisseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.Erica M. Bednar, Charlotte C. Sun, Bethsaida Camacho, John Terrell, Alyssa G. Rieber, Lois M. Ramondetta, Ralph S. Freedman, Karen H. Lu> ;Gynecologic Oncology. 2019 Feb 1
- 23 citationsISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer ProgressionTsz-Lun Yeung, Ching Chou Tsai, Cecilia S. Leung, Chi-Lam Au Yeung, Melissa S. Thompson, Karen H. Lu, Ralph S. Freedman, Michael J. Birrer, Kwong Kwok Wong, Samuel C. Mok> ;Cancers. 2018 Nov 22
- 3 citations2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer CenterRalph S. Freedman, Scott B. Cantor, Kelly W. Merriman, Mary E. Edgerton> ;Clinical Cancer Research. 2016 Feb 1
- Join now to see all
Grant Support
- Autologous Therapeutic Tumor Vaccine + Ifn-GammaNational Center For Research Resources2004
- Phase II Intraperitoneal Rhil 12National Cancer Institute2001–2002
- B7.1 Costimulation In Ovarian CancerNational Cancer Institute2000–2001
- Autologous Therapeutic Tumor Vaccine + IFN Gamma In Ovarian CancerNational Center For Research Resources1999–2000
- IP Priming With Rifng And RIL 2 In IP Adoptive Immunotherapy Of Ovarian CancerNational Center For Research Resources1996–1999
- Ovarian Carcinoma TIL Treatment After IFN Gamma/Il2National Cancer Institute1994–1997
Professional Memberships
- Life Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
